Final overall survival analysis for the RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (mRCC) Meeting Abstract


Authors: Knox, J. J.; Barrios, C. H.; Kim, T. M.; Cosgriff, T.; Srimuninnimit, V.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; Beck, J. T.; Cheung, F. Y.; Yadav, S.; Patel, P. M.; Geoffrois, L.; Schiff, E.; Niolat, J.; Berkowitz, N.; Voi, M.; Motzer, R.
Abstract Title: Final overall survival analysis for the RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (mRCC)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901025
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.4554
Notes: Meeting Abstract: 4554 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer